iShares Nasdaq Profile

111.27
USD 0.73  0.65%
86%
112.0
81%
111.52

iShares Nasdaq Summary

iShares Nasdaq Biotechnology [IBB] is traded in USA and was established on January 21, 2018. The fund is classified under Health category within iShares family. iShares Nasdaq Biotechnology currently have 9.93 B in assets under management (AUM). , while the total return for the last 3 years was 2.01%.
Check iShares Nasdaq Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

iShares Nasdaq Biote Currency Exposure (%)

 % of ETF 
      Currency 

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Churchill Management CorpFund Units1.8 M192.3 M
Bank Of MontrealPut Options57 K6.1 M
Cutler Group LpCall Options324.6 K2.4 M
View iShares Nasdaq Diagnostics

iShares Nasdaq Biote Risk Profiles

iShares Nasdaq Biote Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. iShares Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe iShares Nasdaq price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

iShares Nasdaq Against Markets

Current Ratings

iShares Nasdaq 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
16 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for iShares Nasdaq Biotechnology are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. more
NameiShares Nasdaq Biotechnology
Macroaxis Advice
InstrumentUSA Etf ETF Directory
RegionNorth America
Investment IssuerBlackrock
ExchangeNASDAQ General Markets
Etf FamilyiShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Contact Number800 474 2737
CurrencyUSD - US Dollar
IssuerBlackrock
DescriptioniShares Nasdaq Biotechnology ETF
Inception Date2001-02-05
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management10.37 Billion
Average Trading Valume2.22 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Portfolio ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndMarch 31
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents199
Market MakerVirtu Financial
Total Expense0.47
Management Fee0.47

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas